Novo Nordisk A/S (NVO) Stock Overview
Explore Novo Nordisk A/S’s financial performance, market position, analyst ratings, and future outlook.
Novo Nordisk A/S (NVO)
Key Financials
Key Financials
Market Cap
212B
P/E Ratio
11.67
EPS (TTM)
$4.02
ROE
0.59%
NVO Stock Analysis & Investment Overview (NYSE)
Our AI-powered analysis of Novo Nordisk A/S (NYSE: NVO) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Novo Nordisk A/S's NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of NVO on the NYSE shows an RSI of 48.55, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $9.47 for the NYSE listing.
Key metrics behind Novo Nordisk A/S's NYSE-traded stock include a P/E ratio of 11.67 and a market capitalization of 212B. Combined with our AI analysis, these give both institutional and retail investors a clear view of NVO on the NYSE.